Viewing Study NCT04904302


Ignite Creation Date: 2025-12-25 @ 3:57 AM
Ignite Modification Date: 2026-02-07 @ 11:10 AM
Study NCT ID: NCT04904302
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-20
First Post: 2021-05-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Clear Cell Renal Cell Carcinoma View
None Metastatic Clear Cell Renal Cell Carcinoma View
None Stage IV Renal Cell Cancer AJCC v8 View
Keywords: